Future studies that focus on longitudinal assessments of tau aggregation with tau imaging in psychotic and non-psychotic patients that begin from disease-onset would help to clarify the relationship between the increase in tau deposition observed in the current report and the accelerated trajectory of cognitive decline. The gene discussed is MAPT; the disease is Mental deterioration.